The TNF Paradox in Cancer Progression and Immunotherapy

Front Immunol. 2019 Jul 31:10:1818. doi: 10.3389/fimmu.2019.01818. eCollection 2019.

Authors

Anne Montfort¹, Céline Colacios^{1

2}, Thierry Levade^{1

2

3}, Nathalie Andrieu-Abadie¹, Nicolas Meyer^{1

2

4}, Bruno Ségui^{1

2}

Affiliations

¹ INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
² Université Toulouse III - Paul Sabatier, Toulouse, France.
³ Laboratoire de Biochimie, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France.
⁴ Dermatologie, Institut Universitaire du Cancer (IUCT-O) et CHU de Toulouse, Toulouse, France.

No abstract available

Keywords: CTLA-4; PD-1; immune escape; melanoma; tumor necrosis factor (TNF).

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Humans
Immunotherapy*
Melanoma* / immunology
Melanoma* / pathology
Melanoma* / therapy
Neoplasm Metastasis
Tumor Necrosis Factor-alpha / immunology*

Substances

Tumor Necrosis Factor-alpha